Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Gut Microbes

Integrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum

6 affiliations
  1. 1Laboratorio de Microbioma, División de Investigación, Facultad de Medicina, UNAM, Ciudad de México, Mexico
  2. 2Programa de Inmunología Molecular Microbiana, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
  3. 3Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada
  4. 4Laboratorio de Microbioma, División de Posgrado, Facultad de Medicina, UNAM
  5. 5Director Científico, International Scientific Council for Probiotics, Ciudad de México, S.C. México
  6. 6Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada

Abstract

Pediatric obesity drives extensive metabolic remodeling across gut and systemic compartments, yet integrated multi-omics characterization across the full obesity spectrum remains incomplete. We studied 57 Mexican children stratified by BMI into normal weight (NW, n = 15), overweight (Ow, n = 8), and obese (Ob, n = 34) groups using liver enzyme profiling, untargeted fecal and serum metabolomics, 16S rRNA gut microbiome sequencing, and antimicrobial resistance assessment. Demographic parameters were comparable across groups (p = 0.632), minimizing confounding. Gamma-glutamyl transferase (GGT) showed the strongest obesity association (25.5 ± 6.0 vs. 15.0 ± 3.0 U/L in NW; p < 0.001), outperforming ALT and AST as an early hepatic stress biomarker. Metabolomic profiling identified 1088 altered fecal and 1041 altered serum metabolites (Ob vs. NW), with enriched pathways spanning aromatic amino acid metabolism, one-carbon metabolism, glycolysis/TCA cycle, and nucleotide biosynthesis. Key perturbations included upregulation of kynurenine and 3-nitrotyrosine alongside downregulation of bile acids and purine metabolites. 16S rRNA sequencing revealed 78, 95, and 28 differentially abundant taxa in Ow vs. NW, Ob vs. Ow, and Ob vs. NW comparisons, with elevated beta-diversity dispersion in obesity. Co-abundance network analysis uncovered disrupted metabolite–metabolite and taxon‒taxon interactions, including loss of beneficial SCFA-producing consortia, bile acid dysregulation, and altered amino acid-microbiome coupling. Integration of microbiome and metabolome data revealed high-magnitude genus-metabolite correlations—including Lachnospiraceae with acetate (ρ = 0.92) and Tyzzerella with vulpecholate (ρ = 0.94)—mapping to mechanistic pathways linking SCFAs, bile acids, tryptophan-indole derivatives, and aromatic amino acids to obesity pathogenesis. These findings identify GGT as a sensitive pediatric metabolic biomarker and provide mechanistic insights and therapeutic targets for early intervention.

Related

  1. Use of 16S rRNA Gut Microbiome Analysis to Identify Shared Microbial Signatures Across Metabolic Syndrome Components in Obese Subjects
    Lorenzo Antonetti, Susanna Longo, Marina Cardellini +12
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Integrative microbiome and transcriptome analyses identify parity-associated alterations in rectal fecal microbiota and peripheral immune transcriptional signatures in dairy cows.
    Xin Li, Caixia Shi, Wenguang Zhang +6
    BMC microbiologyPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCDOAJ
  3. Gut Microbiome Signatures Associated with Osteoporotic Vertebral Compression Fracture
    Sujin Jo, Hoonhee Seo, Md Sarower Hossen Shuvo +4
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  4. Revealing gut microbiome signatures in inflammatory bowel disease
    Laura Chulenbayeva, Fernando Garcia Guevara, Madiyar Nurgaziyev +11
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  5. Gut Microbiome Alterations in TAAR5 Knockout Mice and In Silico Ligand Prediction.
    Ilya S Zhukov, Yazen Alnefeesi, Nikita S Gladyshev +6
    International journal of molecular sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{arredondohernandez2026integrated,
  title = {{Integrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum}},
  author = {Rene Arredondo-Hernandez and Patricia Orduña and Alejandro Schcolnik-Cabrera and Gonzalo Castillo-Rojas and Mariana López-Filloy and Pedro Morales-Nava and Andrés Mejía Estrada and Brenda G. Barrios-Plata and Samuel Ponce-de-León-Rosales and Pedro Gutierrez-Castrellon and Liang Li and Yolanda López-Vidal},
  journal = {Gut Microbes},
  year = {2026},
  month = nov,
  doi = {10.1080/19490976.2026.2755119},
  url = {https://doi.org/10.1080/19490976.2026.2755119},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Integrated multi-omics analysis reveals distinct metabolic signatures and gut microbiome alterations across the pediatric obesity spectrum
AU  - Rene Arredondo-Hernandez
AU  - Patricia Orduña
AU  - Alejandro Schcolnik-Cabrera
AU  - Gonzalo Castillo-Rojas
AU  - Mariana López-Filloy
AU  - Pedro Morales-Nava
AU  - Andrés Mejía Estrada
AU  - Brenda G. Barrios-Plata
AU  - Samuel Ponce-de-León-Rosales
AU  - Pedro Gutierrez-Castrellon
AU  - Liang Li
AU  - Yolanda López-Vidal
PY  - 2026
DA  - 2026/11/01
JO  - Gut Microbes
DO  - 10.1080/19490976.2026.2755119
UR  - https://doi.org/10.1080/19490976.2026.2755119
AB  - Pediatric obesity drives extensive metabolic remodeling across gut and systemic compartments, yet integrated multi-omics characterization across the full obesity spectrum remains incomplete. We studied 57 Mexican children stratified by BMI into normal weight (NW, n = 15), overweight (Ow, n = 8), and obese (Ob, n = 34) groups using liver enzyme profiling, untargeted fecal and serum metabolomics, 16S rRNA gut microbiome sequencing, and antimicrobial resistance assessment. Demographic parameters were comparable across groups (p = 0.632), minimizing confounding. Gamma-glutamyl transferase (GGT) showed the strongest obesity association (25.5 ± 6.0 vs. 15.0 ± 3.0 U/L in NW; p < 0.001), outperforming ALT and AST as an early hepatic stress biomarker. Metabolomic profiling identified 1088 altered fecal and 1041 altered serum metabolites (Ob vs. NW), with enriched pathways spanning aromatic amino acid metabolism, one-carbon metabolism, glycolysis/TCA cycle, and nucleotide biosynthesis. Key perturbations included upregulation of kynurenine and 3-nitrotyrosine alongside downregulation of bile acids and purine metabolites. 16S rRNA sequencing revealed 78, 95, and 28 differentially abundant taxa in Ow vs. NW, Ob vs. Ow, and Ob vs. NW comparisons, with elevated beta-diversity dispersion in obesity. Co-abundance network analysis uncovered disrupted metabolite–metabolite and taxon‒taxon interactions, including loss of beneficial SCFA-producing consortia, bile acid dysregulation, and altered amino acid-microbiome coupling. Integration of microbiome and metabolome data revealed high-magnitude genus-metabolite correlations—including Lachnospiraceae with acetate (ρ = 0.92) and Tyzzerella with vulpecholate (ρ = 0.94)—mapping to mechanistic pathways linking SCFAs, bile acids, tryptophan-indole derivatives, and aromatic amino acids to obesity pathogenesis. These findings identify GGT as a sensitive pediatric metabolic biomarker and provide mechanistic insights and therapeutic targets for early intervention.
SN  - 1949-0976
SN  - 1949-0984
ER  -